The Medical Device Innovation Consortium has released a report on how industry and FDA can take patient risk-benefit preferences into consideration when developing and approving new devices. Bill Murray, the organization's CEO spoke to the Gray Sheet about their findings and recommendations. Read the full article here: http://www.thegraysheet.com/a/01150518006